Jan Duerig

514 total citations
12 papers, 34 citations indexed

About

Jan Duerig is a scholar working on Genetics, Hematology and Oncology. According to data from OpenAlex, Jan Duerig has authored 12 papers receiving a total of 34 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 6 papers in Hematology and 5 papers in Oncology. Recurrent topics in Jan Duerig's work include Chronic Lymphocytic Leukemia Research (6 papers), Multiple Myeloma Research and Treatments (3 papers) and Cancer Treatment and Pharmacology (3 papers). Jan Duerig is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Multiple Myeloma Research and Treatments (3 papers) and Cancer Treatment and Pharmacology (3 papers). Jan Duerig collaborates with scholars based in Germany, United Kingdom and Canada. Jan Duerig's co-authors include K. P. Schofield, Barbara Eichhorst, Anna‐Maria Fink, Maria Elisabeth Goebeler, Martina Stauch, Kirsten Fischer, Hartmut Doehner, Lewin Eisele, Ludger Sellmann and Michael Bergmann and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Jan Duerig

11 papers receiving 34 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan Duerig Germany	4	22	20	13	9	8	12	34
Amanda Gillespie-Twardy United States	4	18 0.8×	23 1.1×	11 0.8×	23 2.6×	5 0.6×	8	45
Neus Ruiz‐Xivillé Spain	6	15 0.7×	16 0.8×	15 1.2×	8 0.9×	10 1.3×	8	34
Fabrício Augusto Martinelli de Oliveira Brazil	2	18 0.8×	15 0.8×	8 0.6×	17 1.9×	8 1.0×	5	43
Sophia Sohoni United States	2	27 1.2×	23 1.1×	9 0.7×	13 1.4×	7 0.9×	3	35
Srivalli Gopaluni United States	4	9 0.4×	14 0.7×	10 0.8×	9 1.0×	12 1.5×	8	35
Anna Alperovich United States	4	16 0.7×	27 1.4×	8 0.6×	19 2.1×	7 0.9×	10	42
Katya Ahr United States	3	16 0.7×	29 1.4×	6 0.5×	20 2.2×	18 2.3×	4	45
Magda Alexis France	4	15 0.7×	33 1.6×	18 1.4×	36 4.0×	5 0.6×	9	57
Sonia Fox United Kingdom	4	20 0.9×	20 1.0×	13 1.0×	11 1.2×	22 2.8×	11	41
Rodrigo Santucci Silva United States	4	37 1.7×	39 1.9×	16 1.2×	13 1.4×	4 0.5×	7	48

Countries citing papers authored by Jan Duerig

Since Specialization

Citations

This map shows the geographic impact of Jan Duerig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Duerig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Duerig more than expected).

Fields of papers citing papers by Jan Duerig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Duerig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Duerig. The network helps show where Jan Duerig may publish in the future.

Co-authorship network of co-authors of Jan Duerig

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Duerig. A scholar is included among the top collaborators of Jan Duerig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Duerig. Jan Duerig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Gerken, Guido, et al.. (2021). Risk factors for post-polypectomy bleeding; a retrospective case-control study of a high-volume colonoscopy center. Zeitschrift für Gastroenterologie. 60(10). 1475–1482. 3 indexed citations

Haderk, Franziska, Laura Llaó Cid, Murat Iskar, et al.. (2016). CLL Exosome-Derived Y RNA hY4 Induces TLR7/8-Mediated Inflammation and PD-L1 Expression in Monocytes. Blood. 128(22). 3217–3217. 1 indexed citations

Wuchter, Patrick, Uta Bertsch, Markus Munder, et al.. (2016). Evaluation of Stem Cell Mobilization in Patients with Multiple Myeloma after Lenalidomide-Based Induction Chemotherapy within the GMMG-HD6 Trial. Blood. 128(22). 3373–3373. 2 indexed citations

Merz, Maximilian, Mathias Haenel, Uta Bertsch, et al.. (2015). Clinical Risk Factors for Peripheral Neuropathy in Patients Treated with Subcutaneous or Intravenous Bortezomib for Newly Diagnosed Multiple Myeloma. Blood. 126(23). 4233–4233. 2 indexed citations

Merz, Maximilian, Hans Salwender, Mathias Hänel, et al.. (2014). Subcutaneous Versus Intravenous Bortezomib in Two Different Induction Therapies for Newly Diagnosed Multiple Myeloma – Subgroup Analysis from the GMMG-MM5 Trial. Blood. 124(21). 3475–3475.

Bühler, Andreas, Clemens‐Martin Wendtner, Michael Hallek, et al.. (2013). TP53 Mutation or Deletion and Efficacy with Single-Agent Lenalidomide in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) (CC-5013-CLL-009 Study). Blood. 122(21). 1638–1638. 3 indexed citations

Wendtner, Clemens‐Martin, Michael Hallek, Graeme Fraser, et al.. (2012). Updated Interim Results of the Safety and Efficacy of Different Lenalidomide Starting Dose Regimens in Patients with Relapsed or Refractory (rel/ref) Chronic Lymphocytic Leukemia (CLL) (CC-5013-CLL-009 Study). Blood. 120(21). 3925–3925. 4 indexed citations

Eichhorst, Barbara, Raymonde Busch, Ulrich Duehrsen, et al.. (2011). Cyclophosphamide, Adriamycin, Vincristine and Prednisone Plus Rituximab (CHOP-R) in Fludarabine (F) Refractory Chronic Lymphocytic Leukemia (CLL) or CLL with Autoimmune Cytopenia (AIC) or Richter's Transformation (RT): Final Analysis of a Phase II Study of the German CLL Study Group. Blood. 118(21). 2860–2860. 10 indexed citations

Eisele, Lewin, et al.. (2010). Abnormal Free Light Chain Ratios are Significantly Associated with Clinical Progression in Chronic Lymphocytic Leukemia. 1. 1 indexed citations

10.

Eisele, Lewin, et al.. (2009). Abnormal Free Light Chain Ratios in Chronic Lymphocytic Leukemia: A New Prognostic Factor?.. Blood. 114(22). 1237–1237. 2 indexed citations

11.

Beer, Dirk de, et al.. (2008). Extremely short telomeres and high telomerase activity in T-cell prolymphocytic leukemia (T-PLL): An optimal target for telomerase inhibition with GRN163L?. Journal of Clinical Oncology. 26(15_suppl). 7061–7061. 3 indexed citations

12.

Schofield, K. P., Jan Duerig, G. Rushton, & James Chang. (1999). α₄β₁ integrin‐mediated adhesion of CD34⁺ cells from patients with chronic myeloid leukaemia: influence of IL‐3. British Journal of Haematology. 106(2). 524–527. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact